Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Treasury Shares (2016 - 2025)

Enanta Pharmaceuticals (ENTA) has disclosed Treasury Shares for 4 consecutive years, with $2000.0 as the latest value for Q2 2015.

  • For the quarter ending Q2 2015, Treasury Shares changed 0.0% year-over-year to $2000.0, compared with a TTM value of $2000.0 through Jun 2015, changed 0.0%, and an annual FY2014 reading of $2000.0, changed 0.0% over the prior year.
  • Treasury Shares was $425000.0 for Q4 2025 at Enanta Pharmaceuticals, up from $93000.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $438000.0 in Q4 2024 and bottomed at $81000.0 in Q1 2023.
  • Average Treasury Shares over 5 years is $170300.0, with a median of $111500.0 recorded in 2021.
  • Peak annual rise in Treasury Shares hit 0.0% in 2013, while the deepest fall reached 0.0% in 2013.
  • Year by year, Treasury Shares stood at $2000.0 in 2012, then changed by 0.0% to $2000.0 in 2013, then changed by 0.0% to $2000.0 in 2014, then changed by 0.0% to $2000.0 in 2015.
  • Business Quant data shows Treasury Shares for ENTA at $2000.0 in Q2 2015, $2000.0 in Q1 2015, and $2000.0 in Q4 2014.